{"title":"探索在低收入和中等收入国家的医生减少处方做法的看法:一项混合方法的研究。","authors":"Anjan Khadka, Sammodavardhana Kaundinnyayana, Kumar Roka, Arjun Poudel, Shakti Shrestha","doi":"10.1111/bcpt.70121","DOIUrl":null,"url":null,"abstract":"<p>With the increasing prevalence of potentially inappropriate medications in low- and middle-income countries (LMICs) like Nepal, the role of deprescribing is ever important. However, evidence on how Nepalese doctors perceive deprescribing in their practice is lacking. A sequential explanatory mixed-method study was conducted among 115 doctors at a tertiary-level teaching hospital in central Nepal using a structured questionnaire. Quantitative data from Likert-scale items were analysed descriptively, while thematically analysing open-ended responses. Only 45 doctors (39.1%) had heard of deprescribing, and 77.8% reported practising it. Most doctors (80%) understood the rationale behind each prescription, and 94.3% agreed on ensuring patient comprehension of prescribed medicines. Only 52.4% routinely involved patients in deprescribing decisions, and 31.4% acknowledged prescribing ‘too many drugs’ at times. Qualitative analysis identified three deprescribing-related themes: (1) general understanding: deprescribing viewed as a planned, systematic process to optimize treatment, minimize polypharmacy, reduce costs, and improve safety; (2) Enablers: patient factors, treatment considerations, medication issues, disease process, prescriber competencies and institutional support; (3) barriers: patient resistance, prescribing inertia, knowledge gaps, coordination issues, time constraints, cost and pharmaceutical influences. Doctors demonstrated a moderate understanding of deprescribing but faced several contextual challenges, highlighting the need for targeted education, institutional policies and deprescribing frameworks in LMICs.</p>","PeriodicalId":8733,"journal":{"name":"Basic & Clinical Pharmacology & Toxicology","volume":"137 5","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12497502/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploration of Perceptions of Deprescribing Practices Among Doctors in a Low- and Middle-Income Country: A Mixed-Methods Study\",\"authors\":\"Anjan Khadka, Sammodavardhana Kaundinnyayana, Kumar Roka, Arjun Poudel, Shakti Shrestha\",\"doi\":\"10.1111/bcpt.70121\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>With the increasing prevalence of potentially inappropriate medications in low- and middle-income countries (LMICs) like Nepal, the role of deprescribing is ever important. However, evidence on how Nepalese doctors perceive deprescribing in their practice is lacking. A sequential explanatory mixed-method study was conducted among 115 doctors at a tertiary-level teaching hospital in central Nepal using a structured questionnaire. Quantitative data from Likert-scale items were analysed descriptively, while thematically analysing open-ended responses. Only 45 doctors (39.1%) had heard of deprescribing, and 77.8% reported practising it. Most doctors (80%) understood the rationale behind each prescription, and 94.3% agreed on ensuring patient comprehension of prescribed medicines. Only 52.4% routinely involved patients in deprescribing decisions, and 31.4% acknowledged prescribing ‘too many drugs’ at times. Qualitative analysis identified three deprescribing-related themes: (1) general understanding: deprescribing viewed as a planned, systematic process to optimize treatment, minimize polypharmacy, reduce costs, and improve safety; (2) Enablers: patient factors, treatment considerations, medication issues, disease process, prescriber competencies and institutional support; (3) barriers: patient resistance, prescribing inertia, knowledge gaps, coordination issues, time constraints, cost and pharmaceutical influences. Doctors demonstrated a moderate understanding of deprescribing but faced several contextual challenges, highlighting the need for targeted education, institutional policies and deprescribing frameworks in LMICs.</p>\",\"PeriodicalId\":8733,\"journal\":{\"name\":\"Basic & Clinical Pharmacology & Toxicology\",\"volume\":\"137 5\",\"pages\":\"\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-10-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12497502/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Basic & Clinical Pharmacology & Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.70121\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic & Clinical Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.70121","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Exploration of Perceptions of Deprescribing Practices Among Doctors in a Low- and Middle-Income Country: A Mixed-Methods Study
With the increasing prevalence of potentially inappropriate medications in low- and middle-income countries (LMICs) like Nepal, the role of deprescribing is ever important. However, evidence on how Nepalese doctors perceive deprescribing in their practice is lacking. A sequential explanatory mixed-method study was conducted among 115 doctors at a tertiary-level teaching hospital in central Nepal using a structured questionnaire. Quantitative data from Likert-scale items were analysed descriptively, while thematically analysing open-ended responses. Only 45 doctors (39.1%) had heard of deprescribing, and 77.8% reported practising it. Most doctors (80%) understood the rationale behind each prescription, and 94.3% agreed on ensuring patient comprehension of prescribed medicines. Only 52.4% routinely involved patients in deprescribing decisions, and 31.4% acknowledged prescribing ‘too many drugs’ at times. Qualitative analysis identified three deprescribing-related themes: (1) general understanding: deprescribing viewed as a planned, systematic process to optimize treatment, minimize polypharmacy, reduce costs, and improve safety; (2) Enablers: patient factors, treatment considerations, medication issues, disease process, prescriber competencies and institutional support; (3) barriers: patient resistance, prescribing inertia, knowledge gaps, coordination issues, time constraints, cost and pharmaceutical influences. Doctors demonstrated a moderate understanding of deprescribing but faced several contextual challenges, highlighting the need for targeted education, institutional policies and deprescribing frameworks in LMICs.
期刊介绍:
Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.